Peptidylprolyl isomerase A pseudogene 50 (PPIAP50)

Peptidylprolyl isomerase A pseudogene 50 (PPIAP50) is a classified pseudogene and not a functional protein-coding gene or druggable target. Unlike the functional "peptidylprolyl isomerase A" (PPIA, cyclophilin A), which encodes an enzyme involved in protein folding and cell signaling, PPIAP50 does not produce a functional protein product. There is no evidence for a direct therapeutic or biomarker role; it is annotated as a pseudogene in genomic databases and literature[3][9]. Some pseudogenes can regulate gene expression indirectly through RNA-mediated mechanisms, but there are no data linking PPIAP50 to human disease, drug interaction, or therapeutic targeting[2][9]. Summary of issues: PPIAP50 is commonly annotated in genomic resources as a pseudogene, not a protein-coding gene or therapeutic target. It should not be listed as a target for drugs or disease indications[3][9]. If you intended Peptidylprolyl isomerase A (PPIA, cyclophilin A), that is a functionally distinct entity with established roles in biology and medicine[1][4][5].

Other names

PPIAP50